Luke Clauson,Thomas A. Silvestrini,Tsontcho Ianchulev,Steven John
申请号：
US12973853
公开号：
US08529492B2
申请日:
2010.12.20
申请国别(地区):
US
年份:
2013
代理人:
摘要：
This disclosure relates generally to methods and devices for use in treating eye conditions with implantable drug delivery devices. One method includes introducing an implant into the suprachoroidal space, wherein the interior volume of the implant is plugged with a drug-release material comprising at least one active agent that elutes through at least one opening in the implant, wherein the drug-release material degrades from the interior volume of the implant over a period time.
